Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • Silexion Therapeutics Corp logo
    PR··Health Care·
    Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

    CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion to initiate the Phase 2/3 clinical trial of SIL204 in Germany With approvals now secured in Israel and Germany - the two major regulatory jurisdictions in which Silexion sought clearance - the Company is positioned to initiate the Phase 2/3 trial of SIL204 in locally advanced pancreatic cancer across both countries First patient dosing expected in the coming weeks at one of the activated Israeli or German sites, subject to completion of standard site activation procedures, including contracti

  • Eco Wave Power Global AB logo
    PR··Utilities·
    Eco Wave Power Turns Waves Into Watts With NVIDIA AI Infrastructure and Digital Twins

    MIAMI, June 23, 2026 /PRNewswire/ -- Eco Wave Power is pleased to share that NVIDIA has published a corporate blog featuring the Company titled 'Eco Wave Power Turns Waves Into Watts With NVIDIA AI Infrastructure and Digital Twins.'   Read the full article: https://blogs.nvidia.com/blog/eco-wave-power-ai-digital-twins/For convenience, the full text of the NVIDIA article is reproduced below:Eco Wave Power Turns Waves Into Watts With NVIDIA AI Infrastructure and Digital TwinsJune 22, 2026, by Tenika Versey WalkerThe next era of AI will not be defined by compute alone. Its growth will be determined by energy.As accelerated computing scales across AI factories, agentic

  • Backblaze Inc. logo
    CoreWeave Inc. logo
    PR··Technology·
    Backblaze Announces Five-Year Multi-Exabyte Data Storage Agreement with CoreWeave

    $335M Strategic Agreement Aligns to Strong AI Demand and Establishes Backblaze as a Key Storage Provider Backblaze, Inc. (NASDAQ:BLZE), the cloud storage platform for the AI era, today announced an agreement with CoreWeave, Inc. (NASDAQ:CRWV), The Essential Cloud for AI™. Under the multi-exabyte, $335 million agreement, Backblaze will provide cost-efficient storage capacity that supports portions of CoreWeave’s managed storage infrastructure, helping optimize placement of data across performance tiers while preserving high-performance storage resources for the demands of AI workloads. The Backblaze technology supports HDD-based storage tiers in CoreWeave AI Object Storage. Customers alr

  • MetaVia Inc. logo
    Nasus Pharma Ltd. logo
    PR··Health Care·
    Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th

    NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here. "This week's Life Sciences Virtual Investor Forum brings

  • Rentokil Initial plc logo
    PR··Consumer Discretionary·
    Rentokil Terminix Launches Multi-Brand Digital Advancements to Enhance Customer Experience

    DALLAS, June 23, 2026 (GLOBE NEWSWIRE) -- Experience a smarter way to manage pests. Rentokil Terminix is upgrading its digital lineup to simplify how customers manage their pest control needs, with easier online booking, 24/7 intelligent monitoring, and automated defense systems that work around the clock. Driven by a commitment to customer-centric innovation, Rentokil Terminix is bringing these advanced digital and automated upgrades to its primary customer-facing brands, with further enhancements scheduled to launch later this year.  This multi-staged rollout across the brand portfolio reflects Rentokil Terminix's ongoing focus on sustainability and innovation. By updating and scali

  • Kopin Corporation logo
    PR··Technology·
    Kopin Expands U.S. Operations With New Optics & Photonics Design Center in Dallas, Texas

    New location to focus on accelerating the company’s ability to deliver next‑generation optical interconnects and co-packaged optics for data centers and application specific optical solutions Kopin Corporation (NASDAQ:KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced plans to open a new Optics and Photonics Design Center in Dallas, Texas, further expanding the company’s U.S.‑based engineering footprint and accelerating development of next‑generation Neural I/o™ technology for the rapidly growing AI infrastructure market. Scheduled to open before

  • ESS Tech Inc. logo
    PR··Miscellaneous·
    ESS to Accelerate Sodium-Ion Battery Energy Storage System Development Following Surging Customer Interest

    Company Aligns Resources to Support Expanded Focus on AI Infrastructure and Data Center MarketsESS Tech, Inc. (NYSE:GWH) ("ESS" or the "company"), a leading provider of non-lithium energy storage solutions, today announced strong early customer engagement for its planned U.S.-made sodium-ion battery energy storage system (BESS) offering, focused on short- and medium-duration applications that have historically been served by lithium-ion systems.Since announcing its letter of intent with Alsym Energy seven weeks ago, ESS has generated significant customer interest for sodium-ion solutions across data centers, critical infrastructure, and utility markets, exceeding demand expectations with lim

  • XTI Aerospace Inc. logo
    PR··Technology·
    XTI Aerospace to Participate in Maxim Defense Technology Virtual Panel Discussion June 25

    Dr. Alex Williams, EVP of Technology, Will Join Industry Leaders for Discussion on Domestic Drone Components and Market StructureDALLAS, June 23, 2026 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ:XTIA) ("XTI Aerospace," "XTI," or the "Company"), an aerospace and advanced technology platform and parent company of Drone Nerds, LLC, ("Drone Nerds"), a leading drone solutions platform serving commercial, enterprise and government customers, today announced that Dr. Alex Williams, Executive Vice President, Technology, will represent XTI in the upcoming Maxim Group Research Analysts Virtual Conference on June 25, 2026,

  • Quantum Computing Inc. logo
    PR··Technology·
    Quantum Computing Inc. Completes Acquisition of NHanced Semiconductors, Inc.

    Strategic acquisition launches Fab 2 to accelerate key roadmap initiatives and expands manufacturing capabilitiesHOBOKEN, N.J., June 23, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced the completion of acquiring NHanced Semiconductors, Inc. ("NHanced"), for a combination of cash and QCi stock valued at $73.1 million, subject to customary adjustments, and up to an additional $72.0 million if certain performance targets are achieved (the "Transaction").The acquisition marks an important step in QCi's transition from research-driven innovation and prototyping to scalab

  • Unisys Corporation New logo
    PR··Technology·
    Unisys Named to The Economist's 2026 Global Top 100 Most Loved Workplaces®

    Unisys moves up 42 spots and is recertified as a Most Loved Workplace for the thirdconsecutive year, reflecting strong employee satisfaction and engagementBLUE BELL, Pa., June 23, 2026 /PRNewswire/ -- Unisys (NYSE:UIS) has been named to the 2026 list of Global Top 100 Most Loved Workplaces® by The Economist. Unisys earned the No. 32 spot, a significant increase from its No. 74 placement in 2025, reflecting its continued dedication to equipping employees with the upskilling and resources needed to innovate and deliver meaningful outcomes for clients. This recognition also marks recertification for Unisys as a Most Loved Workplace® for the third consecutive year by the Best Practice Institute

  • ePlus inc. logo
    PR··Technology·
    ePlus Successfully Earns Place on CRN Solution Provider 500 List for 15 Consecutive Years

    HERNDON, Va., June 23, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced that for the fifteenth consecutive year, it has earned a spot on the CRN Solution Provider 500 List. CRN's annual Solution Provider 500 list recognizes North America's largest solution providers by revenue and serves as a prominent benchmark of leading IT services companies. The solution providers on this list are key influencers propelling growth in the IT industry and the global technology channel.In a rapidly changing technology landscape, ePlus offers its customers an ever-expanding selection of solutions and services that span the full technology ecosystem and support their transformation an

  • Esquire Financial Holdings Inc. logo
    PR··Finance·
    Esquire Financial Holdings, Inc. and Signature Bancorporation Inc. Announce Final Exchange Ratio for Proposed Merger

    JERICHO, N.Y. and ROSEMONT, Ill., June 23, 2026 /PRNewswire/ -- Esquire Financial Holdings, Inc. (NASDAQ:ESQ) ("Esquire"), the parent company of Esquire Bank, National Association and Signature Bancorporation, Inc. ("Signature"), the parent company of Signature Bank, announced today the final exchange ratio for the proposed merger based on Signature's sale of all Schedule A Loans. Under the terms of the merger agreement, Signature shareholders were to receive 2.630 shares of Esquire common stock for each share of Signature common stock they own (the "exchange ratio"), subject to

  • Wendy's Company logo
    PR··Consumer Discretionary·
    THE WENDY'S COMPANY NAMES STEVE CIRULIS CHIEF FINANCIAL OFFICER AND CHIEF STRATEGY OFFICER

    Cirulis to Succeed Ken Cook Effective June 23DUBLIN, Ohio, June 23, 2026 /PRNewswire/ -- The Wendy's Company (NASDAQ:WEN) today announced the appointment of Steve Cirulis as Chief Financial Officer and Chief Strategy Officer, effective June 23, 2026. He will report to President and Chief Executive Officer Bob Wright and serve on Wendy's Senior Leadership Team. Cirulis will succeed Ken Cook, who has served as Chief Financial Officer since 2024 and will remain in an advisory position through July to facilitate a smooth transition. Cirulis most recently served as Chief Financial Of

  • Quad Graphics Inc logo
    PR··Consumer Discretionary·
    QuadMed Appoints Michelle Bowers as Vice President of Growth to Drive Strategic Expansion

    SUSSEX, Wis., June 23, 2026 /PRNewswire/ -- QuadMed, a nationally recognized provider of employer-sponsored healthcare solutions, today announced that Michelle Bowers has joined the company as Vice President of Growth, where she will lead strategic sales initiatives and support the next phase of the company's growth strategy. Bowers brings more than 20 years of experience in healthcare, business development, and strategic growth, with a demonstrated history of helping employers, labor organizations, and communities improve healthcare access and outcomes. Throughout her career, s

  • Marsh logo
    PR··Finance·
    Marsh to Host Second Quarter Earnings Investor Call on July 21

    Marsh (NYSE:MRSH), a global leader in risk, reinsurance and capital, people and investments and management consulting, will announce second quarter financial results via news release on Tuesday, July 21, 2026, before the market opens. The news release will be available on the Company’s website. Following the news release, President and CEO John Doyle and COO and CFO Mark McGivney will lead a teleconference with investors at 8:30 a.m. EDT. The discussion will include a question-and-answer session. The live audio webcast will be accessible on the Company's website, and a replay will be available approximately two hours after the event. The webcast is listen-only. Those interested in parti

  • Alpha Cognition Inc. logo
    Milestone Pharmaceuticals Inc. logo
    PR··Health Care·
    Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board

    Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of dedicated service and leadership. "On behalf of the entire Board of Directors, we are pleased that Dr. Wills will serve as Chairman at this important time for Alpha Cognition," said Michael McFadden, Chief Executive Officer of Alpha Cognition, Inc. "He brings a wealth of experience, strategic insight, and a deep understanding of our busi

  • RB Global Inc. logo
    PR··Real Estate·
    IAA Announces New Market Alliance in El Salvador

    RB Global, Inc. (NYSE:RBA) (TSX:RBA), the trusted global partner for insights, services and transaction solutions, today announced that IAA has launched a new Market Alliance in El Salvador with Matus International. The alliance supports IAA’s ongoing international growth strategy by expanding access to its global digital marketplace for customers throughout Central America. As part of the Market Alliance network, Matus International will operate an auction center in the capital city of San Salvador, providing local support and services to customers looking to browse, bid on and purchase vehicles. The auction center is designed to enhance the customer experience by providing in-market ass

  • DiaMedica Therapeutics Inc. logo
    PR··Health Care·
    DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction

    First clinical evaluation of DM199 (rinvecalinase alfa) in fetal growth restriction, a leading cause of stillbirth with no approved pharmacologic treatment DM199 is intended to improve maternal uterine artery blood flow to the placenta without crossing into fetal circulation Fetal Growth Restriction white paper authored by leading maternal-fetal medicine experts released DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced the dosing of the first two patients in an investigator-sponsored Phase 2 trial evaluating DM199 (rinvecalinase alf

  • Rocket Companies Inc. logo
    PR··Finance·
    NYC Suburbs and the Bay Area Are This Spring’s Most Competitive Housing Markets

    Redfin reports more than half of homes are selling above asking price in Newark, San Francisco, San Jose and Nassau County Homebuyers are battling for homes in New York City suburbs and the Bay Area, pushing up prices, according to a new report from Redfin, the real estate brokerage powered by Rocket. Nearly three in five (57.6%) homes in Newark, NJ, sold above their original asking price in May, the highest share of the 50 most populous U.S. metros. The Bay Area followed closely behind, with 57.3% of homes in San Francisco and 53.2% in San Jose selling above asking. Nassau County, NY rounds out the four metro areas where more than half of homes that sold in May went for above asking

  • Nexalin Technology Inc. logo
    PR··Health Care·
    Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

    Dr. Victor Fontenelle Bastos de Lima, an investigator on Nexalin’s recently completed Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 – Congress on Brain, Behavior and Emotions, held in Porto Alegre, Brazil Award-winning research evaluated Nexalin’s DIFS™ 15 mA, 77.5 Hz platform for insomnia symptoms in patients with comorbid anxiety, with the primary reported finding being a significant, durable improvement in sleep quality Independent scientific recognition further strengthens the growing clinical and scientific visibility behind Nexalin’s differentiated, non-invasive frequency-based neurostimulation platform as the Company prepares for product launch in Brazi